Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 15.05.2025
Douglas AG
Q2 2024/25 (January – March 2025)
DOUGLAS Group on track to reach guidance for FY 2024/25 - significantly improved net income
Q2 results impacted by volatile environment and negative calendar effects:
Group sales -2.0% (reported) to 939.0 million euros (like-for-like, “lfl”: -2.5%), stores -0.1% (lfl: -2.4%), E-Com -5.6%; excluding sold-off Dis [ … ]
Thu, 15.05.2025
tonies SE
tonies delivers strong start to the year 2025 - first quarter with EUR 97.2m net revenue
Group revenue in Q1 increases by 22.1% YoY in constant currency (cc) driven by international expansion (+24.1% nominal to EUR 97.2m)
North America continues positive momentum with growth of 37.5% YoY (cc) (+42.4% nominal to EUR 39.7m)
DACH region revenue sli [ … ]
Thu, 15.05.2025
Energiekontor AG
Energiekontor picks up speed during the first quarter of 2025
Bremen, 15 May 2025 – Energiekontor AG (“Energiekontor”), one of the leading German project developers and operators of wind and solar parks, based in Bremen and listed in the General Standard, has vigorously driven project development and the expansion of its own park portfolio in the [ … ]
Thu, 15.05.2025
Flughafen Wien AG
Flughafen Wien AG Generates Positive Results in Q1/2025:
Increase in passenger traffic, revenue and earnings
Passenger growth in Q1/2025: 7.9 million passengers in the Group (+4.6%)
Financial performance indicators in the first quarter of 2025: revenue up 7.4% to € 225.9 million, EBITDA rise of 2.2% to € 81.3 million, EBIT increase of 4.9% [ … ]
Thu, 15.05.2025
Circus SE
Circus SE to be Included in the MSCI Global Micro Cap Index
First-time significant visibility among institutional investors, analysts, and strategists worldwide
Circus SE is the only German company to have its shares newly included in the MSCI Global Micro Cap Index this year
Anticipated global capital inflows driven by inclusion in numerous ETF [ … ]
Thu, 15.05.2025
Deutsche Konsum REIT-AG
PRESS RELEASE
Deutsche Konsum REIT reports stable rental performance in the first half of 2024/2025 with a focus on refinancing
Finalisation of a restructuring plan to secure long-term balance sheet stability expected by end of August
Portfolio adjustments with a potential volume of EUR 350 to 450 million in order to reduce debt by the end of 2 [ … ]
Thu, 15.05.2025
Cantourage Group SE
Not for direct or indirect publication or distribution within or in the United States of America, Australia, Canada or Japan or any other jurisdiction where such publication or distribution would be unlawful. Please note the important information at the end of this announcement.
PRESS RELEASE
Cantourage achieves another record revenue: EUR 11.1 m [ … ]
Thu, 15.05.2025
AT&S Austria Technologie & Systemtechnik AG
AT&S increases revenue in a challenging market environment
Revenue 2024/25 increases to € 1,590 million
Sale of AT&S Korea leads to profit for the year of € 90 million
Cost optimization and efficiency program continued
Customer diversification successfully advanced
Quarterly rather than annual guidance due to current uncertainty [ … ]
Thu, 15.05.2025
thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera Improves Sales and Earnings in Second Quarter
Continued high revenue growth for the electrolysis specialist in the second quarter and first half of 2024/2025
Both thyssenkrupp nucera business areas, green hydrogen and chlor-alkali electrolysis, contributed to sales growth
Strong improvement in earnings thanks to high sales m [ … ]
Thu, 15.05.2025
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
/ Key word(s): AGMEGM
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
15.05.2025 / 07:00 CET/CEST
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
GENEVA (MAY 15, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharma [ … ]